| 000 | 01093 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250511214304.0 | ||
| 264 | 0 | _c19900313 | |
| 008 | 199003s 0 0 eng d | ||
| 022 | _a0140-6736 | ||
| 024 | 7 |
_a10.1016/0140-6736(90)90335-3 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWatkins, J | |
| 245 | 0 | 0 |
_aComplement activation by polystarch and gelatine volume expanders. _h[electronic resource] |
| 260 |
_bLancet (London, England) _cJan 1990 |
||
| 300 |
_a233 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Controlled Clinical Trial; Letter; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aComplement Activation _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aPlasma Substitutes _xpharmacology |
| 650 | 0 | 4 |
_aPolygeline _xpharmacology |
| 650 | 0 | 4 |
_aPolymers _xpharmacology |
| 650 | 0 | 4 |
_aStarch _xpharmacology |
| 700 | 1 | _aWild, G | |
| 700 | 1 | _aAppleyard, T N | |
| 700 | 1 | _aHardy, G | |
| 773 | 0 |
_tLancet (London, England) _gvol. 335 _gno. 8683 _gp. 233 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0140-6736(90)90335-3 _zAvailable from publisher's website |
| 999 |
_c1973892 _d1973892 |
||